Rapidly disintegrating tablets of metoclopramide hydrochloride using novel chemically modified cellulose
Keywords:
Chemically modified cellulose, Microcrystalline cellulose, Metoclopramide hydrochloride, Rapidly disintegrating tablets, SuperdisintegrantAbstract
The purpose of the study was to modify cellulose using hydrochloride salt of 2-aminoethanoyl chloride with optimum hydrophilic and hydrophobic properties to impart it a superdisintegrant activity and also to formulate and evaluate rapidly disintegrating tablets of metoclopramide hydrochloride using this novel chemically modified cellulose. A novel polymer, chemically modified cellulose was synthesized by chemically modifying microcrystalline cellulose with hydrochloride salt of 2-aminoethanoyl chloride. The formation of novel polymer was confirmed by Fourier Transform Infrared (FTIR) and Nuclear Magnetic Resonance (NMR) spectroscopy and by differential scanning calorimetric (DSC) and elemental analysis. The toxicity study proved the novel modified cellulose to be non toxic. Rapidly disintegrating tablets of metoclopramide hydrochloride were prepared using novel modified cellulose and compared for the release of drug with control formulation, prepared using non modified microcrystalline cellulose. The tests like wetting time, water absorption ratio and in vitro disintegration time were carried out to elucidate the relationship between them. The study revealed that novel modified cellulose in a concentration of 2% released the drug faster than at a concentration higher than that. Hence it could be concluded that microcrystalline cellulose, a polymer which is devoid of superdisintegrant activity, can suitably be modified by controlled chemical modification of it with hydrochloride salt of 2-aminoethanoyl chloride or similar groups with optimum hydrophilicity and hydrophobicity to convert it into a superdisintegrant material. It can also be concluded that rapidly disintegrating tablets of metoclopramide hydrochloride can suitably be developed for the efficient management of emesis.Downloads
References
Hirani J, Rathod D, Vadalia K. Orally disintegrating tablets: a
review. Trop J Pharm Res. 2009; 8(2):161-172.
Seager H. Drug delivery products and the zydis fast dissolving dosage. J Pharm Pharmacol.1998; 50: 375-382.
Dobetti L. Fast melting tablets: developments and technologies. Pharm Technol Drug Deliv.2001:44-50.
Shastry S, Nyshadham J, Fix J. Recent technological advances in oral drug delivery: a review. Pharm Sci Technol Today.2000:138-145.
Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier J, Piccerelle P. The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J Pharm. 2004; 278:423-433.
Desai S, Kharade S, Petkar K, Kuchekar B. Optimizing orodissolving tablets of desloratidine by superdisintegrants. The Ind Pharmacist. 2007; 10:83-86.
Koushik D, Dureja H, Saini T. Mouth dissolving tablets: a review. Ind drugs. 2004; 41:187-193.
Cheu P, Welch R, Binder C. Acceptability and disintegration rates of orally disintegrating resperidone tablets in patients with schizophrenia or schizoaffective disorders. Can J Psychiatry. 2004; 50:193-198.
Shu T, Suzuki H, Hironaka K, Ito K. Studies on rapidly disintegrating tablets in oral cavity using coground mixture of mannitol with crosspovidone. Chem Pharm Bull (Tokyo). 2002; 50: 193-198.
Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation design and optimization of mouth dissolving tablets of Nimesulide using vacuum drying technique. AAPS Pharmscitech. 2004; 5: E36.
Chang R, Guo X, Burnside B, Couch R. Fast dissolving tablets. Pharm technol. 2000; 24: 52-58.
Shimizu T, Sugaya M, Nakano Y. Formulation study for lansoprazole fast disintegrating tablets III: design of rapidly disintegrating tablets. Chem Pharm Bull (Tokyo).2003; 51: 121-127.
Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid disintegrating tablets. AAPS Pharmscitech. 2007; 8(2), E1-E7.
Fu Y, Jeong S, Park K. Fast melting tablets based on highly plastic granules. J control Rel. 2005; 109:203-210.
Watanabe A, Hanawa T, Sugihara M, Yamamoto K. Release profiles of phenytoin from new oral dosage form for the elderly. Chem Pharm Bull (Tokyo). 1994; 42: 642-645.
Fu Y, Yang S, Jeong S, Kimamura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste masking and clinical studies. Crit Rev Ther Drug Carrier Syst. 2004; 21: 64-72.
Sugimoto Y, Maejima T, Narisawa S, Matsubara K, Yoshino H. Factors affecting the characteristics of rapidly disintegrating tablets in the mouth prepared by the crystalline transition of amorphous sucrose. Int J Pharm. 2005; 296:64-72.
Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, Piccerelle P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm. 2005; 292:29-41.
Harada T, Narazaki R, Nagira S, Ohwaki T, Aoki S, Iwamoto K. Evaluation of the disintegration properties of commercial famotidine 20 mg orally disintegrating tablets using a simple new test and human sensory test. Chem Pharm Bull (Tokyo). 2006; 54: 1072-1075.
Zakia, N, Awad, G, Mortada, N, Seham S. Enhanced bioavilability of metoclopramide hydrochloride by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucocilliary transport properties. Eur. J. Pharm. Sci. 2007; 32: 296-307.
Dollery, C, Therapeutic Drugs. 2nd ed. London : Churchill Livingstone; 1999.
Hasan E, Amro B, Arafat T, Badwan, A.Assessment of controlled release hydrophilic matrix formulation of metoclopramide hydrochloride. Eur. J. Pharm. Biopharm. 2003; 55: 339-344.
Rowe, R., Handbook of Pharmaceutical Excipients, 4th ed., Pharmaceutical Press, London, (2003).
Morita Y, Tsushima Y, Termoz R, Ajioka J, Takayama K. Evaluation of disintegration time of rapidly disintegrating tablets via a novel method using a CCD camera. Chem Pharm Bull (Tokyo).2002; 50:1181-1186.
Watanabe Y, Yamamoti Y, Fujii M, Kondoh M, Shibata Y. A novel method for predicting disintegration time in the mouth of rapid disintegrating tablet by compaction analysis using Tab AII. Chem Pharm Bull (Tokyo).2004; 52: 1394-1395.
Narazaki R, Harada T, Takami N, Koto Y, Ohwaki T. A new method for disintegration studies of rapid disintegrating tablets. Chem Pharm Bull (Tokyo).2004; 52:704-707.
Swamy P, Arefulla S, Shirsand S, Gandra S., Prashanth B. Orodispersible tablets of meloxicam using disintegrant blends for improved efficacy. Ind. J. Pharm. Sci. 2007; 69 (6): 836-840.
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).